In Vitro Generation of Novel Functionalized Biomaterials for Use in Oral and Dental Regenerative Medicine Applications. Running Title: Fibrin-Agarose Functionalized Scaffolds.

dc.contributor.authorBlanco-Elices, Cristina
dc.contributor.authorEspaña-Guerrero, Enrique
dc.contributor.authorMateu-Sanz, Miguel
dc.contributor.authorSánchez-Porras, David
dc.contributor.authorGarcía-García, Óscar Darío
dc.contributor.authorSánchez-Quevedo, María Del Carmen
dc.contributor.authorFernández-Valadés, Ricardo
dc.contributor.authorAlaminos, Miguel
dc.contributor.authorMartín-Piedra, Miguel Ángel
dc.contributor.authorGarzón, Ingrid
dc.date.accessioned2025-01-07T14:10:28Z
dc.date.available2025-01-07T14:10:28Z
dc.date.issued2020-04-04
dc.description.abstractRecent advances in tissue engineering offer innovative clinical alternatives in dentistry and regenerative medicine. Tissue engineering combines human cells with compatible biomaterials to induce tissue regeneration. Shortening the fabrication time of biomaterials used in tissue engineering will contribute to treatment improvement, and biomaterial functionalization can be exploited to enhance scaffold properties. In this work, we have tested an alternative biofabrication method by directly including human oral mucosa tissue explants within the biomaterial for the generation of human bioengineered mouth and dental tissues for use in tissue engineering. To achieve this, acellular fibrin-agarose scaffolds (AFAS), non-functionalized fibrin-agarose oral mucosa stroma substitutes (n-FAOM), and novel functionalized fibrin-agarose oral mucosa stroma substitutes (F-FAOM) were developed and analyzed after 1, 2, and 3 weeks of in vitro development to determine extracellular matrix components as compared to native oral mucosa controls by using histochemistry and immunohistochemistry. Results demonstrate that functionalization speeds up the biofabrication method and contributes to improve the biomimetic characteristics of the scaffold in terms of extracellular matrix components and reduce the time required for in vitro tissue development.
dc.identifier.doi10.3390/ma13071692
dc.identifier.issn1996-1944
dc.identifier.pmcPMC7178710
dc.identifier.pmid32260417
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7178710/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1996-1944/13/7/1692/pdf?version=1605677745
dc.identifier.urihttps://hdl.handle.net/10668/26196
dc.issue.number7
dc.journal.titleMaterials (Basel, Switzerland)
dc.journal.titleabbreviationMaterials (Basel)
dc.language.isoen
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario San Cecilio
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectbiomaterials
dc.subjectextracellular matrix
dc.subjectfunctionalization
dc.subjectoral and dental tissues
dc.subjecttissue engineering
dc.titleIn Vitro Generation of Novel Functionalized Biomaterials for Use in Oral and Dental Regenerative Medicine Applications. Running Title: Fibrin-Agarose Functionalized Scaffolds.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7178710.pdf
Size:
7.42 MB
Format:
Adobe Portable Document Format